immatics biotechnologies GmbH (IMTXW) — Free Cash Flow Generation Index
immatics biotechnologies GmbH (IMTXW) has a Free Cash Flow Generation Index of 0.88x as of December 2023. Free cash flow of $69.78 Million represents 1% of operating cash flow ($79.08 Million). See IMTXW current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
immatics biotechnologies GmbH Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for immatics biotechnologies GmbH across 4 annual periods. Explore immatics biotechnologies GmbH cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for immatics biotechnologies GmbH (2018–2023)
Year-by-year Free Cash Flow Generation Index for immatics biotechnologies GmbH. For the full company profile including market capitalisation, see immatics biotechnologies GmbH market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.70x | $-12.73 Million | $18.23 Million | $30.96 Million | ▼ -174.5% |
| 2022 | 0.94x | $93.92 Million | $100.13 Million | $6.21 Million | ▼ -3.2% |
| 2019 | 0.97x | $68.73 Million | $70.97 Million | $2.23 Million | ▼ -0.7% |
| 2018 | 0.98x | $20.18 Million | $20.68 Million | $507.00K | — |